Teladoc Health’s acquisition of Livongo continues to haunt its balance sheets as the Purchase, New York-based company posted significant losses in the first half of 2022.
Teladoc said it posted a net loss of $3.1 billion in the second quarter of 2022 and a $9.7 billion loss for the first half of the year. The losses are primarily due to a non-cash goodwill impairment charge related to the Livongo acquisition that totaled $9.6 billion in…